← Leaderboards
Liang-I Kang
University Of Pittsburgh At Pittsburgh
$137,661
Attributed
$137,661
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.2K · FY2011–13$50K$37.5K$25K$12.5K$0
'11
'12
'13
Funding mix
By agency
NIH$137,661 · 1
By mechanism
F30$137,661 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- George K Michalopoulos$12,892,897
- Steven H. Belle$61,210,153
- Donghun Shin$7,694,142
- Amy L Hartman$17,863,276
- Jun Chen$22,616,112
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAffinityAlcoholismAlteplaseArchitectureArchivesCell BehaviorCell Culture TechniquesCell Differentiation ProcessCell MaturationCellsChronicChronic HepatitisChronic Hepatitis CCicatrixCirrhosisCostDrug Or Chemical Tissue DistributionEtiologyExtracellularExtracellular MatrixExtracellular Matrix ProteinsFda ApprovedActive Sites
Grant awards (3)
Role for tissue-type plasminogen activator in suppression of hepatic fibrosis$47,232
F30 · FY2013 · DK · contact PI
Role for tissue-type plasminogen activator in suppression of hepatic fibrosis$47,232
F30 · FY2012 · DK · contact PI
Role for tissue-type plasminogen activator in suppression of hepatic fibrosis$43,197
F30 · FY2011 · DK · contact PI